Metraipolis › archive › dc_c9239fa93950
Evaluating immunoreactivity of hybridoma-derived antibody mixtures generated against AU-565 cell line for diagnosis and immunotherapy of breast cancer — Europe PMC PMID:42106673
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42106673
- DOI
- 10.1186/s12885-[numero omesso]-7
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T13:20:44.682Z
- SHA-256 of the archived text
b30c58eb46c86eaf9e0e8216783441f8a431f06d42bda2fed549ae26e5c27e99- Stable URL of this page
https://metraipolis.com/documento/dc_c9239fa93950
How to cite
Evaluating immunoreactivity of hybridoma-derived antibody mixtures generated against AU-565 cell line for diagnosis and immunotherapy of breast cancer — Europe PMC PMID:42106673 — Europe PMC (en), https://europepmc.org/article/MED/42106673 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c9239fa93950 (Metraipolis archive dc_c9239fa93950, sha256 b30c58eb46c86eaf9e0e8216783441f8a431f06d42bda2fed549ae26e5c27e99)
BibTeX
@misc{dcc9239fa93950,
title = {Evaluating immunoreactivity of hybridoma-derived antibody mixtures generated against AU-565 cell line for diagnosis and immunotherapy of breast cancer — Europe PMC PMID:42106673},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42106673},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c9239fa93950; sha256 b30c58eb46c86eaf9e0e8216783441f8a431f06d42bda2fed549ae26e5c27e99},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42106673. Agents can read the archived copy with the MCP tool read_document.